Bioenergetic Adaptations in Chemoresistant Ovarian Cancer Cells

Bioenergetic Adaptations in Chemoresistant Ovarian Cancer Cells

Abstract Earlier investigations have revealed that tumor cells undergo metabolic reprogramming and mainly derive their cellular energy from aerobic glycolysis rather than oxidative phosphorylation even in the presence of oxygen. However, recent studies have shown that certain cancer cells display in...

Full description

Bibliographic Details
Main Authors:	Sajad Dar, Jasdeep Chhina, Ismail Mert, Dhananjay Chitale, Thomas Buekers, Hareena Kaur, Shailendra Giri, Adnan Munkarah, Ramandeep Rattan
Format:	Article
Language:	English
Published:	Nature Publishing Group 2017-08-01
Series:	Scientific Reports
Online Access:	https://doi.org/10.1038/s41598-017-09206-0

Similar Items

Ovarian cancer modulates the immunosuppressive function of CD11b+Gr1+ myeloid cells via glutamine metabolism
by: Mary P. Udumula, et al.
Published: (2021-11-01)

Metformin: An Emerging New Therapeutic Option for Targeting Cancer Stem Cells and Metastasis
by: Ramandeep Rattan, et al.
Published: (2012-01-01)

Metformin Suppresses Ovarian Cancer Growth and Metastasis with Enhancement of Cisplatin Cytotoxicity In Vivo
by: Ramandeep Rattan, et al.
Published: (2011-05-01)

Standby letters of credit in international trade
by: Chhina, Ramandeep Kaur
Published: (2012)

MICU1 drives glycolysis and chemoresistance in ovarian cancer
by: Prabir K. Chakraborty, et al.
Published: (2017-05-01)

Preclinical therapeutic potential of a nitrosylating agent in the treatment of ovarian cancer.
by: Shailendra Giri, et al.
Published: (2014-01-01)

Mechanisms Involved in Chemoresistance in Ovarian Cancer
by: Kar-San Ling, et al.
Published: (2005-09-01)

Determination of chemoresistance of ovarian cancer cells in vitro
by: K. A. Kuzin, et al.
Published: (2019-12-01)

Targeting Mitochondria for Treatment of Chemoresistant Ovarian Cancer
by: Edith Emmings, et al.
Published: (2019-01-01)

Cancer stem cells and chemoresistance in ovarian cancer
by: Coulson-Gilmer, Camilla Lucette
Published: (2017)

Chemoresistance in human ovarian cancer: the role of apoptotic regulators
by: Thompson Winston E, et al.
Published: (2003-10-01)

Characterization of ovarian tumor-initiating cells and mechanisms of chemoresistance
by: Chau, Wing-ka, et al.
Published: (2014)

Role of FOXM1 in ovarian cancer tumorigenesis and chemoresistance
by: Zhao, Fung, et al.
Published: (2015)

Chemoresistance is mediated by ovarian cancer leader cells in vitro
by: Nazanin Karimnia, et al.
Published: (2021-09-01)

Role of FOXM1 in ovarian cancer tumorigenesis and chemoresistance
by: Zhao, Fung
Published: (2013)

The Role of Plasma Gelsolin in Epithelial Ovarian Cancer Chemoresistance
by: Asare-Werehene, Meshach
Published: (2020)

Co-evolution of matrisome and adaptive adhesion dynamics drives ovarian cancer chemoresistance
by: Elina A. Pietilä, et al.
Published: (2021-06-01)

The use of chiral template methodology towards the synthesis of Î±-amino acids
by: Chhina, Ramandeep
Published: (2003)

Nanoceria: a rare-earth nanoparticle as a novel anti-angiogenic therapeutic agent in ovarian cancer.
by: Shailendra Giri, et al.
Published: (2013-01-01)

SIRT1 Regulates the Chemoresistance and Invasiveness of Ovarian Carcinoma Cells
by: David Hamisi Mvunta, et al.
Published: (2017-08-01)

Exosomes secreted by chemoresistant ovarian cancer cells promote angiogenesis
by: Zhang Li, et al.
Published: (2021-01-01)

The Role of Tumor-Associated Macrophages in the Progression and Chemoresistance of Ovarian Cancer
by: Marek Nowak, et al.
Published: (2020-05-01)

Subtype specific biomarkers associated with chemoresistance in epithelial ovarian cancer
by: Abhilash Deo, et al.
Published: (2020-01-01)

The Potential Role of iNOS in Ovarian Cancer Progression and Chemoresistance
by: Michal Kielbik, et al.
Published: (2019-04-01)

TGFBI promoter hypermethylation correlating with paclitaxel chemoresistance in ovarian cancer
by: Wang Ning, et al.
Published: (2012-01-01)

Suppression of Annexin A11 in Ovarian Cancer: Implications in Chemoresistance
by: Jin Song, et al.
Published: (2009-06-01)

Bioenergetics
Published: (2012)

The deubiquitinase USP11 promotes ovarian cancer chemoresistance by stabilizing BIP
by: Xiaolin Zhu, et al.
Published: (2021-07-01)

Oncologic trogocytosis of an original stromal cells induces chemoresistance of ovarian tumours.
by: Arash Rafii, et al.
Published: (2008-01-01)

Alternative treatment of chemoresistant, recurrent or advanced ovarian cancer. Part I
by: Jacek R. Wilczyński
Published: (2011-06-01)

Alternative treatment of chemoresistant, recurrent or advanced ovarian cancer. Part II
by: Jacek R. Wilczyński, et al.
Published: (2011-10-01)

Leveraging Genomics, Transcriptomics, and Epigenomics to Understand the Biology and Chemoresistance of Ovarian Cancer
by: Sandra Muñoz-Galván, et al.
Published: (2021-08-01)

Substrate Stiffness Modulates the Growth, Phenotype, and Chemoresistance of Ovarian Cancer Cells
by: Yali Fan, et al.
Published: (2021-08-01)

Autophagic adaptation to oxidative stress alters peritoneal residential macrophage survival and ovarian cancer metastasis
by: Houjun Xia, et al.
Published: (2020-09-01)

Ascitis as a unique microenvironment of tumors in ovarian cancer: interaction with prognosis and chemoresistance
by: A. B. Villert, et al.
Published: (2019-07-01)

Postoperative recurrence of epithelial ovarian cancer patients and chemoresistance related protein analyses
by: Zhengmao Zhang, et al.
Published: (2019-03-01)

Can Stemness and Chemoresistance Be Therapeutically Targeted via Signaling Pathways in Ovarian Cancer?
by: Lynn Roy, et al.
Published: (2018-07-01)

The SP1-12LOX axis promotes chemoresistance and metastasis of ovarian cancer
by: Qi Zhang, et al.
Published: (2020-05-01)

Contribution of FPR and TLR9 to hypoxia-induced chemoresistance of ovarian cancer cells
by: Cai Y, et al.
Published: (2018-12-01)

Cytogenetic Evolution of Human Ovarian Cell Lines Associated with Chemoresistance and Loss of Tumorigenicity
by: Stéphanie Struski, et al.
Published: (2003-01-01)